 technical, with an
inability to treat the perforators in 8 of 34 limbs
(23.5%).201 Further studies to support perforator ablation
during the initial procedure in these unique situations
are warranted.
Guideline 4.2. For patients with varicose veins (C2)
and persistent or recurrent symptoms after previous
complete ablation of incompetent superï¬cial truncal
veins, we suggest treatment of IPVs if they are